Owner Bristol-Myers Squibb Company Oxigene, Inc.

Inventors Chaplin, David; Peck, Ronald; Edvardsen, Klaus; Pero, Ronald; Lee, Francis, Y.

Agent Cullen & Co

Pub. Number AU-B-2002246827

PCT Pub. Number WO2002/056692

Priority 60/258,195 22.12.00 US

Filing date 20 December 2001

Wipo publication date 30 July 2002

Acceptance publication date 21 February 2008

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/05 (2006.01)

A61K 31/09 (2006.01)

A61K 31/282 (2006.01)

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/4745 (2006.01)

A61K 31/661 (2006.01) - Phosphorus acids or esters thereof not having PC bonds, e.g. fosfosal, dichlorvos, malathion

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 36/18 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines - Magnoliophyta (angiosperms)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups